{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:18:06Z","timestamp":1770967086921,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,21]],"date-time":"2011-08-21T00:00:00Z","timestamp":1313884800000},"content-version":"vor","delay-in-days":201,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.leukres.2010.07.034","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T04:22:11Z","timestamp":1282537331000},"page":"260-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia"],"prefix":"10.1016","volume":"35","author":[{"given":"Antonio R.","family":"Lucena-Araujo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Morato","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina Dias","family":"Leite-Cueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme Augusto","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto Passeto","family":"Falcao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Magalh\u00e3es","family":"Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.07.034_bib0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","article-title":"The cellular geography of aurora kinases","volume":"4","author":"Carmena","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.leukres.2010.07.034_bib0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1593\/neo.09154","article-title":"Aurora-A expression is independently associated with chromosomal instability in colorectal cancer","volume":"11","author":"Baba","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.leukres.2010.07.034_bib0015","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/00016340902835927","article-title":"Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients","volume":"88","author":"Zhang","year":"2009","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.leukres.2010.07.034_bib0020","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1158\/1078-0432.CCR-07-5268","article-title":"Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer","volume":"14","author":"Nadler","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.leukres.2010.07.034_bib0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/bjs.6011","article-title":"Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy","volume":"95","author":"Tanaka","year":"2008","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.leukres.2010.07.034_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12308-008-0019-3","article-title":"Analysis of Aurora kinase A expression in CD34(+) blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia","volume":"2","author":"Ye","year":"2009","journal-title":"J. Hematop."},{"key":"10.1016\/j.leukres.2010.07.034_bib0035","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2007-07-099325","article-title":"Aurora kinase inhibitory VX-680 increases Bax\/Bcl-2 ratio and induces apoptosis in Aurora-A-high acute myeloid leukemia","volume":"111","author":"Huang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.034_bib0040","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3324\/haematol.12148","article-title":"Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts","volume":"93","author":"Walsby","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2010.07.034_bib0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/jncimonographs\/lgn003","article-title":"Clinical significance of the most common chromosome translocations in adult acute myeloid leukemia","author":"Mrozek","year":"2008","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.leukres.2010.07.034_bib0050","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-11-254441","article-title":"Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities amongst 5,876 younger adult patients treated in the UK Medical Research Council trials","author":"Grimwade","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.034_bib0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2141.2008.07160.x","article-title":"The expression of DeltaNTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity","volume":"142","author":"Lucena-Araujo","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2010.07.034_bib0115","series-title":"ISCN (2005): an International System for Human Cytogenetic Nomenclature","author":"Shaffer","year":"2005"},{"issue":"9","key":"10.1016\/j.leukres.2010.07.034_bib0065","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.83.9.2934","article-title":"Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization","volume":"83","author":"Pinkel","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2010.07.034_bib0070","first-page":"3074","article-title":"Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia","volume":"93","author":"Kiyoi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.034_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cancergencyto.2009.12.005","article-title":"Segmental amplification of MLL gene associated with high expression of AURKA and AURKB genes in a case of acute monoblastic leukemia with complex karyotype","volume":"198","author":"Oliveira","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.leukres.2010.07.034_bib0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrc1526","article-title":"Aurora-A \u2013 a guardian of poles","volume":"5","author":"Marumoto","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"June (6)","key":"10.1016\/j.leukres.2010.07.034_bib0085","first-page":"589","article-title":"Targeting Aurora-2 kinase in cancer","volume":"2","author":"Warner","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.leukres.2010.07.034_bib0090","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/leu.2010.15","article-title":"Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias","volume":"24","author":"Moore","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.07.034_bib0095","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ijc.1200","article-title":"Association of centrosomal kinase STK15\/BTAK mRNA expression with chromosomal instability in human breast cancers","volume":"92","author":"Miyoshi","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.leukres.2010.07.034_bib0100","article-title":"Biology of Aurora A kinase: implications in cancer manifestation and therapy","author":"Karthigeyan","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.leukres.2010.07.034_bib0105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/blood-2006-05-025049","article-title":"MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation","volume":"109","author":"Giles","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.034_bib0110","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1172\/JCI30890","article-title":"Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency","volume":"117","author":"Shah","year":"2007","journal-title":"J. Clin. Invest."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610003772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610003772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:57:24Z","timestamp":1758934644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610003772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0145212610003772"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.07.034","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High expression of AURKA and AURKB is associated with unfavorable cytogenetic abnormalities and high white blood cell count in patients with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2010.07.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}